⌘K
Loading ticker…
Travere Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Travere Therapeutics, Inc. Common Stock (TVTX) has a 3-month relative strength percentile of 97 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 88. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.8%, relative volume 2.11×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 97, Market Stance is mixed at 47, A/D rating B
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
TVTX is in a stage 2 uptrend, week 8. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 27.8% / 70.5%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
TVTX is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $88M notional. Top 3 carry $233M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $88M |
| XBIState Street SPDR S&P Biotech ETF | 1.14% | $85M |
| IWMiShares Russell 2000 ETF | 0.08% | $60M |
| VXFVanguard Extended Market ETF | 0.04% | $30M |
| IWOiShares Russell 2000 Growth ETF | 0.15% | $19M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $3M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TVTX Jan avg: 1.17% median: 2.92% win: 50% σ: 15.16% n: 4 2022-04-12 → 2026-05-29 | TVTX Feb avg: -4.00% median: -2.63% win: 25% σ: 8.39% n: 4 2022-04-12 → 2026-05-29 | TVTX Mar avg: -3.26% median: 0.61% win: 50% σ: 8.72% n: 4 2022-04-12 → 2026-05-29 | TVTX Apr avg: 2.71% median: -4.09% win: 40% σ: 27.05% n: 5 2022-04-12 → 2026-05-29 | TVTX May avg: -1.19% median: -7.24% win: 40% σ: 24.61% n: 5 2022-04-12 → 2026-05-29 | TVTX Jun avg: -0.22% median: 1.24% win: 50% σ: 10.55% n: 4 2022-04-12 → 2026-05-29 (current) | TVTX Jul avg: 7.38% median: 8.15% win: 75% σ: 8.36% n: 4 2022-04-12 → 2026-05-29 | TVTX Aug avg: 2.32% median: 6.27% win: 50% σ: 14.48% n: 4 2022-04-12 → 2026-05-29 | TVTX Sep avg: 9.75% median: 14.32% win: 50% σ: 39.57% n: 4 2022-04-12 → 2026-05-29 | TVTX Oct avg: 8.17% median: 6.54% win: 50% σ: 34.08% n: 4 2022-04-12 → 2026-05-29 | TVTX Nov avg: -0.51% median: -1.19% win: 50% σ: 6.22% n: 4 2022-04-12 → 2026-05-29 | TVTX Dec avg: 12.04% median: 6.19% win: 75% σ: 21.75% n: 4 2022-04-12 → 2026-05-29 |